The National Institute of Allergy and Infectious Diseases trial reportedly found that Remdesivir Accelerates Recovery from Advanced COVID-19 and that patients had a 31 per cent faster time to recovery than those who received placebo.
IP: 184.108.40.206. Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.